Advertisement
Screener

SI-BONE, INC. (SIBN) EBITDA

SI-BONE, INC. (SIBN) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$3.13M*; Operating income -$4.81M; Depreciation and amortization $1.68M*.
  • 2026-03-31: Basis Reported; EBITDA -$3.48M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$825,000.00; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$3.90M*; Operating income -$5.38M; Depreciation and amortization $1.49M*.

Complete source-backed ebitda history.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$3.13M*-$4.81M$1.68M*$56.01M-5.58%*$1.54M*$777.00K*$11.46M$5.22M(m)$0.00
2026-03-31Reported-$3.48M(m)(m)(m)-6.61%$1.08M-$2.36M$10.64M$4.19M(m)$0.00
2025-12-31Reported-$825,000.00(m)(m)(m)-1.46%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$3.90M*-$5.38M$1.49M*$48.66M-8.01%*$2.96M*$2.33M*$9.81M$4.24M(m)$0.00
2025-06-30Reported-$5.64M*-$7.00M$1.37M*$48.63M-11.59%*$2.10M*$173.00K*$9.82M$4.31M(m)$0.00
2025-03-31Reported-$6.2M(m)(m)(m)-13.11%$2.07M-$4.91M$9.60M$4.53M(m)$0.00
2024-12-31Reported-$4.28M(m)(m)(m)-8.74%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$6.55M*-$7.63M$1.08M*$40.34M-16.23%*$3.04M*$302.00K*$8.44M$3.99M(m)$0.00
2024-06-30Reported-$9.09M*-$10.08M$992.00K*$39.97M-22.73%*$3.11M*-$6.33M*$8.39M$4.35M(m)$0.00
2024-03-31Reported-$10.95M(m)(m)(m)-28.93%$2.08M-$7.57M$8.00M$4.34M(m)$0.00
2023-12-31Reported-$10.93M(m)(m)(m)-28.14%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$9.64M*-$11.17M$1.53M*$34.01M-28.33%*$1.41M*-$2.07M*$7.04M$3.92M(m)$0.00
2023-06-30Reported-$10.73M*-$11.96M$1.24M*$33.30M-32.21%*$2.71M*-$3.59M*$6.32M$3.66M(m)$0.00
2023-03-31Reported-$10.21M(m)(m)(m)-31.21%$2.58M-$10.75M$5.92M$3.29M(m)$0.00
2022-12-31Reported-$10.29M(m)(m)(m)-32.21%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$12.62M*-$13.57M$945.00K*$26.43M-47.75%*$3.57M*-$6.53M*$4.17M$3.09M(m)$0.00
2022-06-30Reported-$17.09M*-$17.88M$792.00K*$25.59M-66.79%*$2.00M*-$14.84M*$3.46M$3.48M(m)$0.00
2022-03-31Reported-$16.16M(m)(m)(m)-72.00%$2.27M-$13.51M$2.98M$3.58M(m)$0.00
2021-12-31Reported-$13.28M(m)(m)(m)-52.64%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$12.61M*-$13.20M$591.00K*$22.29M-56.57%*$423.00K*-$9.31M*$2.48M$3.29M(m)$0.00
2021-06-30Reported-$12.46M*-$12.96M$505.00K*$22.19M-56.14%*$2.21M*-$8.15M*$2.38M$3.15M(m)(m)
2021-03-31Reported-$11.24M(m)(m)(m)-54.96%$1.98M-$9.36M$2.20M$2.96M(m)(m)
2020-12-31Reported-$7.53M(m)(m)(m)-33.99%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$8.39M*-$8.68M$281.00K*$20.37M-41.20%*$480.00K*-$5.55M*$2.58M$2.78M(m)(m)
2020-06-30Reported-$9.88M*-$10.14M$256.00K*$14.05M-70.35%*$380.00K*-$7.87M*$2.12M$2.17M(m)(m)
2020-03-31Reported-$11.63M(m)(m)(m)-69.16%$884.00K-$9.36M$1.93M$2.09M(m)(m)
2019-12-31Reported-$8.28M(m)(m)(m)-41.80%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$10.41M*-$10.58M$175.00K*$16.18M-64.31%*$746.00K*-$7.12M*$1.63M$1.87M(m)(m)
2019-06-30Reported-$7.94M*-$8.14M$202.00K*$16.32M-48.64%*$481.00K*-$8.40M*$1.59M$1.95M(m)(m)
2019-03-31Reported-$8.61M(m)(m)(m)-57.41%$412.00K-$7.08M$1.53M$1.68M(m)(m)
2018-12-31Reported-$4.12M(m)(m)(m)-26.38%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$2.86M*-$3.04M$180.00K*(m)(m)$62.00K*-$2.53M*$1.22M$1.37M(m)(m)
2018-06-30Reported-$1.51M*-$1.70M$188.00K*(m)(m)$497.00K*-$1.26M*$1.18M$1.30M(m)(m)
2018-03-31Reported-$2.75M(m)(m)(m)-21.63%$218.00K-$4.41M$1.05M$1.21M(m)(m)
2017-12-31Reported-$1.45M(m)(m)(m)-10.49%(m)(m)(m)(m)(m)(m)
2017-09-30Reported(m)-$5.04M(m)(m)(m)(m)(m)$1.33M$1.47M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$16.56M(m)(m)(m)-8.24%$8.41M-$675.00K$41.05M$17.45M(m)$0.00
2024-12-31Reported-$30.87M(m)(m)(m)-18.46%$10.50M-$12.43M$35.06M$16.56M(m)$0.00
2023-12-31Reported-$41.5M(m)(m)(m)-29.88%$7.80M-$18.71M$29.47M$15.03M(m)$0.00
2022-12-31Reported-$56.16M(m)(m)(m)-52.77%$9.51M-$41.66M$15.71M$13.63M(m)$0.00
2021-12-31Reported-$49.58M(m)(m)(m)-55.00%$6.39M-$39.53M$10.43M$12.44M(m)$0.00
2020-12-31Reported-$37.44M(m)(m)(m)-51.01%$2.56M-$30.66M$8.90M$9.46M(m)(m)
2019-12-31Reported-$35.23M(m)(m)(m)-52.35%$2.44M-$31.63M$6.79M$7.28M(m)(m)
2018-12-31Reported-$11.24M(m)(m)(m)-20.30%$942.00K-$14.52M$4.83M$5.38M(m)$0.00
2017-12-31Reported-$16.34M(m)(m)(m)-34.05%$478.00K-$17.53M$5.11M$5.51M(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
SpyGlass Pharma, Inc. (SGP)United States$0.925B
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
IRADIMED CORP (IRMD)United States$1.089B52.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33